Charles Zhu
Stock Analyst at LifeSci Capital
(4.92)
# 201
Out of 4,668 analysts
288
Total ratings
69.7%
Success rate
29.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Charles Zhu
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IDYA IDEAYA Biosciences | Maintained: Buy | $58 | $39.11 | +48.30% | 55 | Aug 19, 2026 | |
| KURA Kura Oncology | Maintained: Buy | $28 | $11.71 | +139.11% | 34 | Aug 13, 2026 | |
| PBLS Parabilis Medicines | Maintained: Buy | $42 | $39.58 | +6.11% | 4 | Aug 13, 2026 | |
| STRO Sutro Biopharma | Maintained: Buy | $54 | $21.16 | +155.20% | 5 | Aug 12, 2026 | |
| IMNM Immunome | Reiterated: Buy | $40 | $28.08 | +42.45% | 20 | Aug 12, 2026 | |
| ADAG Adagene | Maintained: Buy | $8 | $4.09 | +95.60% | 9 | Aug 12, 2026 | |
| TARA Protara Therapeutics | Rated: Buy | $26 → $20 | $3.90 | +412.82% | 20 | Aug 11, 2026 | |
| RVMD Revolution Medicines | Maintained: Buy | $291 | $211.74 | +37.44% | 30 | Aug 8, 2026 | |
| CNTX Context Therapeutics | Downgraded: Hold | $6 → $2 | $0.5197 | +284.84% | 8 | Aug 8, 2026 | |
| ZYME Zymeworks | Maintained: Buy | $34 | $26.57 | +27.96% | 28 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $2.36 | +154.24% | 13 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $46 | $29.52 | +55.83% | 3 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $16.23 | +72.52% | 11 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $4.23 | +183.69% | 19 | Jul 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $7.02 | n/a | 1 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $23.51 | n/a | 3 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $20 | $4.07 | n/a | 6 | Jan 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $35.31 | n/a | 4 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 → $39 | $27.00 | n/a | 4 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $0.52 | n/a | 3 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $37.99 | n/a | 3 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $20 | $1.30 | n/a | 4 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $2.00 | $0.42 | n/a | 1 | Nov 29, 2022 |
IDEAYA Biosciences
Aug 19, 2026
Maintained: Buy
Price Target: $58
Current: $39.11
Upside: +48.30%
Kura Oncology
Aug 13, 2026
Maintained: Buy
Price Target: $28
Current: $11.71
Upside: +139.11%
Parabilis Medicines
Aug 13, 2026
Maintained: Buy
Price Target: $42
Current: $39.58
Upside: +6.11%
Sutro Biopharma
Aug 12, 2026
Maintained: Buy
Price Target: $54
Current: $21.16
Upside: +155.20%
Immunome
Aug 12, 2026
Reiterated: Buy
Price Target: $40
Current: $28.08
Upside: +42.45%
Adagene
Aug 12, 2026
Maintained: Buy
Price Target: $8
Current: $4.09
Upside: +95.60%
Protara Therapeutics
Aug 11, 2026
Rated: Buy
Price Target: $26 → $20
Current: $3.90
Upside: +412.82%
Revolution Medicines
Aug 8, 2026
Maintained: Buy
Price Target: $291
Current: $211.74
Upside: +37.44%
Context Therapeutics
Aug 8, 2026
Downgraded: Hold
Price Target: $6 → $2
Current: $0.5197
Upside: +284.84%
Zymeworks
Aug 6, 2026
Maintained: Buy
Price Target: $34
Current: $26.57
Upside: +27.96%
Aug 6, 2026
Maintained: Buy
Price Target: $6
Current: $2.36
Upside: +154.24%
Aug 5, 2026
Maintained: Buy
Price Target: $46
Current: $29.52
Upside: +55.83%
Jul 30, 2026
Maintained: Buy
Price Target: $28
Current: $16.23
Upside: +72.52%
Jul 11, 2026
Maintained: Buy
Price Target: $12
Current: $4.23
Upside: +183.69%
Jun 18, 2025
Initiated Coverage: Buy
Price Target: $22
Current: $7.02
Upside: n/a
May 24, 2024
Maintained: Buy
Price Target: $14
Current: $23.51
Upside: n/a
Jan 2, 2024
Maintained: Buy
Price Target: $12 → $20
Current: $4.07
Upside: n/a
Jun 13, 2023
Reiterated: Buy
Price Target: $26
Current: $35.31
Upside: n/a
May 9, 2023
Maintained: Buy
Price Target: $45 → $39
Current: $27.00
Upside: n/a
Mar 17, 2023
Maintained: Buy
Price Target: $5
Current: $0.52
Upside: n/a
Jan 3, 2023
Maintained: Hold
Price Target: n/a
Current: $37.99
Upside: n/a
Jan 3, 2023
Maintained: Buy
Price Target: $30 → $20
Current: $1.30
Upside: n/a
Nov 29, 2022
Initiated Coverage: Buy
Price Target: $2.00
Current: $0.42
Upside: n/a